270 related articles for article (PubMed ID: 30648120)
1. Defensive Driving: Directing HIV-1 Vaccine-Induced Humoral Immunity to the Mucosa with Chemokine Adjuvants.
Gary EN; Kutzler MA
J Immunol Res; 2018; 2018():3734207. PubMed ID: 30648120
[TBL] [Abstract][Full Text] [Related]
2. Mucosal Vaccination for Prevention of HIV Infection and AIDS.
Aldovini A
Curr HIV Res; 2016; 14(3):247-59. PubMed ID: 26957199
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines.
Belyakov IM; Ahlers JD
Curr Med Chem; 2011; 18(26):3953-62. PubMed ID: 21824096
[TBL] [Abstract][Full Text] [Related]
4. Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands.
Pavot V; Climent N; Rochereau N; Garcia F; Genin C; Tiraby G; Vernejoul F; Perouzel E; Lioux T; Verrier B; Paul S
Biomaterials; 2016 Jan; 75():327-339. PubMed ID: 26539801
[TBL] [Abstract][Full Text] [Related]
5. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
[TBL] [Abstract][Full Text] [Related]
6. Translational Mini-Review Series on Vaccines for HIV: T lymphocyte trafficking and vaccine-elicited mucosal immunity.
Kaufman DR; Barouch DH
Clin Exp Immunol; 2009 Aug; 157(2):165-73. PubMed ID: 19604255
[TBL] [Abstract][Full Text] [Related]
7. Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses.
Sun X; Zhang H; Xu S; Shi L; Dong J; Gao D; Chen Y; Feng H
Virol J; 2017 Aug; 14(1):163. PubMed ID: 28830557
[TBL] [Abstract][Full Text] [Related]
8. CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine.
Gary EN; Kathuria N; Makurumidze G; Curatola A; Ramamurthi A; Bernui ME; Myles D; Yan J; Pankhong P; Muthumani K; Haddad E; Humeau L; Weiner DB; Kutzler MA
Vaccine; 2020 Mar; 38(11):2626-2635. PubMed ID: 32057572
[TBL] [Abstract][Full Text] [Related]
9. Novel mucosal DNA-MVA HIV vaccination in which DNA-IL-12 plus cholera toxin B subunit (CTB) cooperates to enhance cellular systemic and mucosal genital tract immunity.
Maeto C; Rodríguez AM; Holgado MP; Falivene J; Gherardi MM
PLoS One; 2014; 9(9):e107524. PubMed ID: 25215887
[TBL] [Abstract][Full Text] [Related]
10. Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques.
Petitdemange C; Kasturi SP; Kozlowski PA; Nabi R; Quarnstrom CF; Reddy PBJ; Derdeyn CA; Spicer LM; Patel P; Legere T; Kovalenkov YO; Labranche CC; Villinger F; Tomai M; Vasilakos J; Haynes B; Kang CY; Gibbs JS; Yewdell JW; Barouch D; Wrammert J; Montefiori D; Hunter E; Amara RR; Masopust D; Pulendran B
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830870
[TBL] [Abstract][Full Text] [Related]
11. Divergent HIV-1-Directed Immune Responses Generated by Systemic and Mucosal Immunization with Replicating Single-Cycle Adenoviruses in Rhesus Macaques.
Matchett WE; Anguiano-Zarate SS; Nehete PN; Shelton K; Nehete BP; Yang G; Dorta-Estremera S; Barnette P; Xiao P; Byrareddy SN; Villinger F; Hessell AJ; Haigwood NL; Sastry KJ; Barry MA
J Virol; 2019 May; 93(10):. PubMed ID: 30842321
[TBL] [Abstract][Full Text] [Related]
12. Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses.
McKay PF; Mann JF; Pattani A; Kett V; Aldon Y; King D; Malcolm RK; Shattock RJ
J Control Release; 2017 Mar; 249():74-83. PubMed ID: 28115243
[TBL] [Abstract][Full Text] [Related]
13. DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.
Chege GK; Burgers WA; Müller TL; Gray CM; Shephard EG; Barnett SW; Ferrari G; Montefiori D; Williamson C; Williamson AL
Vaccine; 2017 Feb; 35(6):929-937. PubMed ID: 28069361
[TBL] [Abstract][Full Text] [Related]
14. Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice.
Wang J; Shu T; Deng W; Zheng Y; Liao M; Ye X; Han L; He P; Zheng X; Li T; Feng Y; Hu F; Li P; Sun C; Chen L; Li F; Feng L
J Virol; 2021 May; 95(12):. PubMed ID: 33789991
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.
Belyakov IM; Ahlers JD
Curr Top Microbiol Immunol; 2012; 354():157-79. PubMed ID: 21203884
[TBL] [Abstract][Full Text] [Related]
16. Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen.
Jones DI; Pollara JJ; Johnson-Weaver BT; LaBranche CC; Montefiori DC; Pickup DJ; Permar SR; Abraham SN; Maddaloni M; Pascual DW; Staats HF
J Virol; 2019 Jul; 93(14):. PubMed ID: 31068425
[TBL] [Abstract][Full Text] [Related]
17. Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines.
Belyakov IM; Berzofsky JA
Immunity; 2004 Mar; 20(3):247-53. PubMed ID: 15030769
[TBL] [Abstract][Full Text] [Related]
18. Thymic stromal lymphopoietin (TSLP) acts as a potent mucosal adjuvant for HIV-1 gp140 vaccination in mice.
Van Roey GA; Arias MA; Tregoning JS; Rowe G; Shattock RJ
Eur J Immunol; 2012 Feb; 42(2):353-63. PubMed ID: 22057556
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunology of HIV infection.
Xu H; Wang X; Veazey RS
Immunol Rev; 2013 Jul; 254(1):10-33. PubMed ID: 23772612
[TBL] [Abstract][Full Text] [Related]
20. Vaccines, adjuvants and key factors for mucosal immune response.
Correa VA; Portilho AI; De Gaspari E
Immunology; 2022 Oct; 167(2):124-138. PubMed ID: 35751397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
